Immix Biopharma Files Annual Report for 2025
Ticker: IMMX · Form: ARS · Filed: 2026-04-06T16:41:51-04:00
Sentiment: neutral
Topics: annual-report, security-holders, pharmaceuticals
TL;DR
Immix Biopharma filed its 2025 ARS on 4/6/26. Check it for company updates.
AI Summary
Immix Biopharma, Inc. filed an Annual Report to Security Holders (ARS) on April 6, 2026, for the period ending December 31, 2025. The company's mailing address is 10573 W. Pico Blvd. #58, Los Angeles, CA 90064, and its business address is 11400 West Olympic Blvd. Suite 200, Los Angeles, CA 90064. Immix Biopharma is involved in the Pharmaceutical Preparations industry.
Why It Matters
This filing provides shareholders with an update on the company's performance and financial standing for the fiscal year 2025. It is a standard disclosure for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine annual filing and does not contain new material information that would immediately impact risk.
Key Numbers
- 2025-12-31 — Period of Report (The end date for the reporting period covered by the ARS.)
- 2026-04-06 — Filing Date (The date the ARS was officially filed with the SEC.)
Key Players & Entities
- Immix Biopharma, Inc. (company) — Filer
- 0001873835 (company) — CIK
- 454869378 (company) — EIN
- DE (company) — State of Incorp.
- 1231 (company) — Fiscal Year End
- 001-41159 (company) — File No.
- 26841800 (company) — Film No.
- 2834 (company) — SIC Code
- 03 (company) — CF Office
FAQ
What type of filing is this?
This is an Annual Report to Security Holders (ARS) filing.
When was this filing accepted by the SEC?
The filing was accepted on 2026-04-06 at 16:41:51.
What is the period of report for this filing?
The period of report is 2025-12-31.
What is Immix Biopharma, Inc.'s business address?
The business address is 11400 West Olympic Blvd. Suite 200, Los Angeles, CA 90064.
What industry does Immix Biopharma, Inc. operate in?
Immix Biopharma, Inc. operates in the Pharmaceutical Preparations industry (SIC Code 2834).
From the Filing
EDGAR Filing Documents for 0001493152-26-015324 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form ARS - Annual Report to Security Holders: SEC Accession No. 0001493152-26-015324 Filing Date 2026-04-06 Accepted 2026-04-06 16:41:51 Documents 1 Period of Report 2025-12-31 Effectiveness Date 2026-04-06 Document Format Files Seq Description Document Type Size 1 ARS formars.pdf ARS 1874276 Complete submission text file 0001493152-26-015324.txt 2582744 Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064 Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084 Immix Biopharma, Inc. (Filer) CIK : 0001873835 (see all company filings) EIN. : 454869378 | State of Incorp.: DE | Fiscal Year End: 1231 Type: ARS | Act: 34 | File No.: 001-41159 | Film No.: 26841800 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)